Vir Biotechnology (VIR) FCF Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - | -45.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.52 Mn |
| Dec 31, 2025 | 68,341.00 |
| Sep 30, 2025 | -6.26 Mn |
| Jun 30, 2025 | -755,851.00 |
| Mar 31, 2025 | -241,491.00 |
| Dec 31, 2024 | -7,228.00 |
| Sep 30, 2024 | -127,576.00 |
| Jun 30, 2024 | 794,723.00 |
| Mar 31, 2024 | -451.00 |
| Dec 31, 2023 | -69,771.00 |
| Sep 30, 2023 | -607,199.00 |
| Jun 30, 2023 | -1.28 Mn |
| Mar 31, 2023 | -25,405.00 |
| Dec 31, 2022 | 4,630.00 |
| Sep 30, 2022 | 13,457.00 |
| Jun 30, 2022 | 223,051.00 |
| Mar 31, 2022 | 459,330.00 |
| Dec 31, 2021 | 487,143.00 |
| Sep 30, 2021 | 255,340.00 |
| Jun 30, 2021 | 11,144.00 |
| Mar 31, 2021 | -369,423.00 |
| Dec 31, 2020 | -83,362.00 |
| Sep 30, 2020 | -45,030.00 |
| Jun 30, 2020 | 128,748.00 |
| Mar 31, 2020 | 4,472.00 |
| Dec 31, 2019 | -284,452.00 |